• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

启动子去甲基化上调人前列腺癌中的基因表达:体外和计算机模拟分析

Promoter Demethylation Upregulates Gene Expression in Human Prostate Cancer: In Vitro and In Silico Analysis.

作者信息

Rocha Sandra M, Sousa Inês, Gomes Inês M, Arinto Patrícia, Costa-Pinheiro Pedro, Coutinho Eduarda, Santos Cecília R, Jerónimo Carmen, Lemos Manuel C, Passarinha Luís A, Socorro Sílvia, Maia Cláudio J

机构信息

CICS-UBI-Health Sciences Research Center, Universidade da Beira Interior, 6201-506 Covilhã, Portugal.

Department of Medical Sciences, Institute of Biomedicine-iBiMED, Universidade de Aveiro, 3810-193 Aveiro, Portugal.

出版信息

Life (Basel). 2021 Nov 17;11(11):1251. doi: 10.3390/life11111251.

DOI:10.3390/life11111251
PMID:34833128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8618799/
Abstract

The Six Transmembrane Epithelial Antigen of the Prostate () is an oncogene overexpressed in several human tumors, particularly in prostate cancer (PCa). However, the mechanisms involved in its overexpression remain unknown. It is well known that epigenetic modifications may result in abnormal gene expression patterns, contributing to tumor initiation and progression. Therefore, this study aimed to analyze the methylation pattern of the gene in PCa versus non-neoplastic cells. Bisulfite amplicon sequencing of the CpG island at the gene promoter showed a higher methylation level in non-neoplastic PNT1A prostate cells than in human PCa samples. Bioinformatic analysis of the GEO datasets also showed the gene promoter as being demethylated in human PCa, and a negative association with mRNA expression was observed. These results are supported by the treatment of non-neoplastic PNT1A cells with DNMT and HDAC inhibitors, which induced a significant increase in mRNA expression. In addition, the involvement of HDAC in the regulation of mRNA expression was corroborated by a negative association between mRNA expression and and in human PCa. In conclusion, our work indicates that overexpression in PCa can be driven by the hypomethylation of gene promoter.

摘要

前列腺六次跨膜上皮抗原(STEAP)是一种在多种人类肿瘤中过度表达的癌基因,尤其是在前列腺癌(PCa)中。然而,其过度表达所涉及的机制仍不清楚。众所周知,表观遗传修饰可能导致异常的基因表达模式,促进肿瘤的发生和发展。因此,本研究旨在分析PCa与非肿瘤细胞中STEAP基因的甲基化模式。STEAP基因启动子处CpG岛的亚硫酸氢盐扩增子测序显示,非肿瘤性PNT1A前列腺细胞中的甲基化水平高于人类PCa样本。对GEO数据集的生物信息学分析也显示,人类PCa中STEAP基因启动子去甲基化,并且观察到与STEAP mRNA表达呈负相关。用DNA甲基转移酶(DNMT)和组蛋白去乙酰化酶(HDAC)抑制剂处理非肿瘤性PNT1A细胞可诱导STEAP mRNA表达显著增加,这支持了上述结果。此外,人类PCa中STEAP mRNA表达与HDAC1和HDAC2呈负相关,证实了HDAC参与STEAP mRNA表达的调控。总之,我们的研究表明,PCa中STEAP的过度表达可能是由STEAP基因启动子的低甲基化驱动的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644f/8618799/48829b28c7aa/life-11-01251-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644f/8618799/3f4436e88e52/life-11-01251-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644f/8618799/b343d1663158/life-11-01251-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644f/8618799/c8c2f8ee3664/life-11-01251-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644f/8618799/7178491a3fd7/life-11-01251-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644f/8618799/48829b28c7aa/life-11-01251-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644f/8618799/3f4436e88e52/life-11-01251-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644f/8618799/b343d1663158/life-11-01251-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644f/8618799/c8c2f8ee3664/life-11-01251-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644f/8618799/7178491a3fd7/life-11-01251-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644f/8618799/48829b28c7aa/life-11-01251-g005.jpg

相似文献

1
Promoter Demethylation Upregulates Gene Expression in Human Prostate Cancer: In Vitro and In Silico Analysis.启动子去甲基化上调人前列腺癌中的基因表达:体外和计算机模拟分析
Life (Basel). 2021 Nov 17;11(11):1251. doi: 10.3390/life11111251.
2
Expression of STEAP1 and STEAP1B in prostate cell lines, and the putative regulation of STEAP1 by post-transcriptional and post-translational mechanisms.STEAP1和STEAP1B在前列腺细胞系中的表达,以及转录后和翻译后机制对STEAP1的假定调控。
Genes Cancer. 2014 Mar;5(3-4):142-51. doi: 10.18632/genesandcancer.13.
3
Proteomic analysis of STEAP1 knockdown in human LNCaP prostate cancer cells.人LNCaP前列腺癌细胞中STEAP1基因敲低的蛋白质组学分析。
Biochim Biophys Acta Mol Cell Res. 2023 Oct;1870(7):119522. doi: 10.1016/j.bbamcr.2023.119522. Epub 2023 Jun 12.
4
STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.STEAP1在前列腺癌和前列腺上皮内瘤变病变中过度表达,并且与Gleason评分呈正相关。
Urol Oncol. 2014 Jan;32(1):53.e23-9. doi: 10.1016/j.urolonc.2013.08.028. Epub 2013 Nov 13.
5
Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PET.用⁸⁹Zr免疫正电子发射断层扫描技术对前列腺癌中STEAP1调控进行标注。
J Nucl Med. 2014 Dec;55(12):2045-9. doi: 10.2967/jnumed.114.145185. Epub 2014 Nov 5.
6
STEAP1 protein overexpression is an independent marker for biochemical recurrence in prostate carcinoma.STEAP1 蛋白过表达是前列腺癌生化复发的独立标志物。
Histopathology. 2013 Nov;63(5):678-85. doi: 10.1111/his.12226. Epub 2013 Sep 11.
7
Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.前列腺癌中EFEMP1的表观遗传调控:生物学相关性及临床潜力
J Cell Mol Med. 2014 Nov;18(11):2287-97. doi: 10.1111/jcmm.12394. Epub 2014 Sep 11.
8
Six-transmembrane epithelial antigen of the prostate 1 expression promotes ovarian cancer metastasis by aiding progression of epithelial-to-mesenchymal transition.前列腺六跨膜上皮抗原 1 的表达通过促进上皮间质转化的进展促进卵巢癌转移。
Histochem Cell Biol. 2020 Aug;154(2):215-230. doi: 10.1007/s00418-020-01877-7. Epub 2020 May 7.
9
STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession.STEAP1 抑制乳腺癌转移,并与上皮间质转化过程相关。
Clin Breast Cancer. 2019 Feb;19(1):e195-e207. doi: 10.1016/j.clbc.2018.08.010. Epub 2018 Aug 30.
10
Six-transmembrane epithelial antigen of the prostate 1 accelerates cell proliferation by targeting c-Myc in liver cancer cells.前列腺六跨膜上皮抗原1通过靶向肝癌细胞中的c-Myc促进细胞增殖。
Oncol Lett. 2021 Jul;22(1):546. doi: 10.3892/ol.2021.12807. Epub 2021 May 24.

引用本文的文献

1
STEAP3 promotes colon cancer cell proliferation and migration via regulating histone acetylation.STEAP3 通过调控组蛋白乙酰化促进结肠癌细胞的增殖和迁移。
Hum Genet. 2024 Mar;143(3):343-355. doi: 10.1007/s00439-024-02646-5. Epub 2024 Mar 13.
2
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.用 STEAP1 嵌合抗原受体 T 细胞和肿瘤局部 IL-12 免疫疗法靶向治疗晚期前列腺癌。
Nat Commun. 2023 Apr 11;14(1):2041. doi: 10.1038/s41467-023-37874-2.
3
STEAP1 regulation and its influence modulating the response of LNCaP prostate cancer cells to bicalutamide, enzalutamide and apalutamide.

本文引用的文献

1
Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines.肼屈嗪和帕比司他可减轻前列腺癌细胞系的恶性特性。
Pharmaceuticals (Basel). 2021 Jul 13;14(7):670. doi: 10.3390/ph14070670.
2
Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response.前列腺癌发生、进展及治疗反应中的染色质与表观遗传失调
Cancers (Basel). 2021 Jul 2;13(13):3325. doi: 10.3390/cancers13133325.
3
HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer.
STEAP1 的调控及其对 LNCaP 前列腺癌细胞对比卡鲁胺、恩杂鲁胺和阿帕鲁胺反应的影响。
Mol Med Rep. 2023 Feb;27(2). doi: 10.3892/mmr.2023.12939. Epub 2023 Jan 20.
4
The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis.STEAP1 在泛癌中的预后价值和免疫作用:基于数据的分析结果。
Oxid Med Cell Longev. 2022 Mar 11;2022:8297011. doi: 10.1155/2022/8297011. eCollection 2022.
组蛋白去乙酰化酶 5 缺失损害 RB 对致癌基因的抑制作用,并赋予癌症对 CDK4/6 抑制剂的耐药性。
Cancer Res. 2021 Mar 15;81(6):1486-1499. doi: 10.1158/0008-5472.CAN-20-2828. Epub 2021 Jan 8.
4
Epigenetic regulation of prostate cancer.前列腺癌的表观遗传调控
Genes Dis. 2019 Nov 9;7(4):606-613. doi: 10.1016/j.gendis.2019.10.018. eCollection 2020 Dec.
5
A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos.STEAP1 调控胃癌细胞在体外和体内的增殖、迁移和侵袭的研究。
J Cell Mol Med. 2020 Dec;24(24):14217-14230. doi: 10.1111/jcmm.16038. Epub 2020 Oct 30.
6
Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials.使用组蛋白去乙酰化酶(HDAC)抑制剂协同增强癌症治疗效果:临床试验的契机
Front Genet. 2020 Sep 11;11:578011. doi: 10.3389/fgene.2020.578011. eCollection 2020.
7
Epigenetic mechanisms and the hallmarks of cancer: an intimate affair.表观遗传机制与癌症特征:一段密切关系。
Am J Cancer Res. 2020 Jul 1;10(7):1954-1978. eCollection 2020.
8
STEAP1 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway.STEAP1 通过 JAK2/STAT3 信号通路促进肺腺癌的转移和上皮-间充质转化。
Biosci Rep. 2020 Jun 26;40(6). doi: 10.1042/BSR20193169.
9
Six-transmembrane epithelial antigen of the prostate 1 expression promotes ovarian cancer metastasis by aiding progression of epithelial-to-mesenchymal transition.前列腺六跨膜上皮抗原 1 的表达通过促进上皮间质转化的进展促进卵巢癌转移。
Histochem Cell Biol. 2020 Aug;154(2):215-230. doi: 10.1007/s00418-020-01877-7. Epub 2020 May 7.
10
A short guide to histone deacetylases including recent progress on class II enzymes.组蛋白去乙酰化酶简介,包括 II 类酶的最新进展。
Exp Mol Med. 2020 Feb;52(2):204-212. doi: 10.1038/s12276-020-0382-4. Epub 2020 Feb 19.